Dr. Kate Tkaczuk, MD
Claim this profileUniversity of Maryland Baltimore
Studies Breast Cancer
1 reported clinical trial
1 drug studied
Area of expertise
1Breast Cancer
PIK3CA positive
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Kate Tkaczuk, MD is currently running
More about Kate Tkaczuk, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Kate Tkaczuk, MD has experience with
- Evexomostat
Breakdown of trials Kate Tkaczuk, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kate Tkaczuk, MD specialize in?
Kate Tkaczuk, MD focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved PIK3CA positive patients, or patients who are Stage IV.
Is Kate Tkaczuk, MD currently recruiting for clinical trials?
Yes, Kate Tkaczuk, MD is currently recruiting for 1 clinical trial in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Kate Tkaczuk, MD has studied deeply?
Yes, Kate Tkaczuk, MD has studied treatments such as Evexomostat.
What is the best way to schedule an appointment with Kate Tkaczuk, MD?
Apply for one of the trials that Kate Tkaczuk, MD is conducting.
What is the office address of Kate Tkaczuk, MD?
The office of Kate Tkaczuk, MD is located at: University of Maryland Baltimore, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland Baltimore.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.